Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study of a Reduced-toxicity "Submyeloablative" Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies
Sponsor: Nantes University Hospital
Summary
The goal of this prospective study is to assess the overall mortality (whether related to relapse/progression or toxicity - TRM-) at one year after allogeneic stem cell transplantation prepared by a so-called reduced-toxicity "submyeloablative" conditioning regimen in patients with hematological malignancies.
Official title: Phase II Study of a Reduced-toxicity " Submyeloablative " Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
82
Start Date
2009-01
Completion Date
2012-01
Last Updated
2026-09-14
Healthy Volunteers
No
Conditions
Interventions
Fludarabine, Busulfan, Thymoglobuline
Locations (3)
Institut Paoli Calmettes
Marseille, France
CHU de Nantes
Nantes, France
CHU de Bordeaux
Pessac, France